Top compounds associated with response to ADAM18


Feature Type Standardized
Nominal ANOVA
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.081 0.03
mRNA CAY10594 CTRPv2 pan-cancer AAC -0.084 0.03
mRNA SMER-3 CTRPv2 pan-cancer AAC -0.085 0.03
mRNA lovastatin CTRPv2 pan-cancer AAC -0.081 0.03
mRNA PF-543 CTRPv2 pan-cancer AAC 0.082 0.03
mRNA Roscovitine GDSC1000 pan-cancer AAC -0.11 0.03
mRNA ciclopirox CTRPv2 pan-cancer AAC 0.07 0.04
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.076 0.04
mRNA Bortezomib FIMM pan-cancer AAC -0.3 0.04
mRNA IPR-456 CTRPv2 pan-cancer AAC -0.08 0.04
Download CSV